Recombinant desulfatohirudin as a substitute for heparin during cardiopulmonary bypass.
Bernabei
A
A
Rao
A K
AK
Niewiarowski
S
S
Colman
R W
RW
Sun
L
L
Edmunds
L H
LH
D002315:Cardiopulmonary Bypass; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D005344:Fibrinopeptide A / Q000032:analysis*; D006493:Heparin / Q000494:pharmacology / Q000627:therapeutic use; D024764:Hirudin Therapy; D006629:Hirudins / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008955:Models, Cardiovascular; D009504:Neutrophils / Q000187:drug effects; D010446:Peptide Fragments / Q000097:blood*; D015539:Platelet Activation / Q000187:drug effects; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; D005344:Fibrinopeptide A; D006493:Heparin; C060225:desirudin